Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies
Bay, Jacques-Olivier, Dhédin, Nathalie, Goerner, Martin, Vannier, Jean-Pierre, Marie-Cardine, Aude, Stamatoullas, Aspasia, Jouet, Jean-Pierre, Yakoub-Agha, Ibrahim, Tabrizi, Reza, Faucher, Catherine, Diez-Martin, Jose-Luis, Nunez, Gomez, Parody, Rocio, Milpied, Noël, Espérou, Helène, Garban, Frédéric, Galambrun, Claire, Kwiatkovski, Fabrice, Darlavoix, Isabelle, Zinaï, Amina, Fischer, Alain, Michallet, Mauricette, Vernant, Jean-Paul
Published in Transplantation (27.09.2005)
Published in Transplantation (27.09.2005)
Get more information
Journal Article
Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease
DARTOIS, Céline, FREYER, Gilles, MICHALLET, Mauricette, HENIN, Emilie, YOU, Benoit, DARLAVOIX, Isabelle, VERMOT-DESROCHES, Claudine, TRANCHAND, Brigitte, GIRARD, Pascal
Published in Clinical pharmacokinetics (01.01.2007)
Published in Clinical pharmacokinetics (01.01.2007)
Get full text
Journal Article
Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease: Exposure-Effect population model of inolimomab
Dartois, Céline, Freyer, Gilles, Michallet, Mauricette, Hénin, Emilie, You, Benoît, Darlavoix, Isabelle, Vermot-Desroches, Claudine, Tranchand, Brigitte, Girard, Pascal
Published in Clinical pharmacokinetics (2007)
Get full text
Published in Clinical pharmacokinetics (2007)
Journal Article